Merck ' s Biosimilar to AbbVie ' s Humira Wins FDA Approval Merck ' s Biosimilar to AbbVie ' s Humira Wins FDA Approval

The U.S. Food and Drug Administration approved Merck& Co Inc ' s biosimilar to AbbVie Inc ' s blockbuster rheumatoid arthritis treatment Humira (adalimumab), the health agency said on Tuesday.FDA Approvals

Source: Medscape Medical News Headlines - July 24, 2019 Category: Consumer Health News Tags: Rheumatology News Source Type: news